Experiment 1123994

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationBEZWODA,WR: DERMAN,DP: WEAVING,A: NISSENBAUM,M:. (1984). TREATMENT OF ESOPHAGEAL CANCER WITH VINDESINE: AN OPEN TRIAL.. 68(5)
Amount utilized
Compound isolated
DiseaseAN OPEN TRIAL ON 52 PATIENTS WITH ESOPHAGEAL CANCER. DOSE GIVEN BY CONTINUOUS INFUSION FOR 48 HOURS,FOLLOWED BY WEEKLY ADMINISTRATION FOR FOUR WEEKS (IV) AND THEN BIMONTHLY MAINTANCE THERAPY. 14 PATIENTS (27%) RESPONDED. 12 PATIENTS HAD DISEASE STABILIZATION FOR 3 MONTHS. TOXIC EFFECTS INCLUDE LEUKOPENIA,THROMBOCYTOPENIA,THROMBOCYTOSIS,NEUROLOGIC TOXICITY AND NEUROTOXICITY. 1 PATIENT DIED FROM ASPIRATION PNEUMONIA ASSOCIATED WITH LEUKOPENIA.
Dose amount3.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE